Press release
FlyPharma Conference Europe 2023 shares industry collaboration initiatives and explores the future of pharma logistics
On 10-11 October 2023, the seventh FlyPharma Conference Europe successfully concluded in Vienna, Austria.FlyPharma Europe, a conference and exhibition for the pharmaceutical logistics industry, brought together industry leaders, regulators, and logistics service providers to discuss the latest innovations and best practices in pharmaceutical and life science transportation. Attendees enjoyed informative presentations and productive networking opportunities over the two-day event. FlyPharma Europe 2023's success proves its status as a vital platform for advancing the industry and establishing valuable partnerships among key stakeholders.
The event welcomed some familiar faces from previous conferences as well as many new ones in attendance during the course of the two days, and the conference was positively received by delegates.
With a global audience of pharma and logistics experts, Vienna was chosen as FlyPharma's host city to discuss the most recent supply chain challenges and industry best practices. The conference's main focus was to explore ways to collaborate and expand both in Vienna and beyond, with an emphasis on supply chain hot topics and opportunities such as digitization and sustainability. Vienna AirportCity offered significant support to the conference as its host sponsor.
The event began with a pre-conference welcome reception and drinks, held on 9 October. The reception took place in Office Park 4, Vienna AirportCity and offered delegates the chance to 'break the ice' and meet prior to the main event.
The conference launched on 10 October with a networking breakfast. FlyPharma Europe Chair, Geert Leroy, opened the conference before welcoming to the stage a variety of expert pharma and logistics speakers. Leroy outlined the theme of day 1, which gave an insight into each supply chain stakeholder's key processes. Wolfgang Scheibenpflug, Senior Vice President Real Estate and Landside Management at Vienna Airport, delivered a welcome address to the audience, speaking about Vienna Airport and the developments it has made in recent years. Scheibenpflug then introduced the Austrian State Secretary, Mr Florian Tursky, who gave a speech on Vienna's strengths, the challenges the city has faced and recent investment into the AirportCity.
Keynote speaker Maria Kounenaki, Executive Director, Pharma Supply Chain at Bristol Myers Squibb, then gave a talk on the next decade of life science logistics, which discussed the impact this sector is expected to have on the whole supply chain. Peter Reulbach, who is Senior Manager Cargo Business Development - AirportCity Development - Real Estate and Landside Development at Vienna Airport, spoke on how the role of the airport has developed over time and future strategies for supply chain modernization.
The morning's networking and refreshments break was sponsored by Rickenbacker International Airport, who shared a presentation on their facilities and current market trends. A lively exhibition area proved an excellent opportunity for delegates to network.
Up next in the main conference room was Carolin Gerstenmaier, Head of Industry Development at Lufthansa Cargo AG, to discuss an airline's perspective on flying pharmaceuticals and the revelation of air cargo's pivotal role in the pharmaceutical industry, posing questions such as: 'why does flying pharma remain a captivating spectacle?'
Luiz Barberini, Operations Manager - External Manufacturing Latin America at Bayer, gave a well-received address highlighting that, during the last mile of a product's journey, it is critical that handling standards remain high and operational processes remain consistent, compliant and efficient. Following Barberini was Christian Koxholt, Vice President Pharma and Healthcare Europe at Kühne + Nagel AG, tackling the impact of product life cycle in pharmaceuticals and the role of mutual supply chain design with the LSP.
There then followed a break for lunch and networking, which was sponsored by DB Schenker; their presentation covered the company's dedicated pharma services and commitment to sustainable logistics.
Christina Norén, Corporate QA GDP Manager at Octapharma, was the first to speak after lunch on how the quality of a product can be maintained during its journey, discussing topics such as sharing quality expectations with logistics partners, assessing suitability of partners, and compliance challenges and approach. Mohamed Nouh, Business Development Director - Software and IoT at SkyCell AG, explored the future and direction of digitalization, including the crucial need for resilient pharmaceutical supply chains in an era marked by constant disruptions.
During the afternoon break, delegates were treated to traditional apple strudel and Viennese coffee, sponsored by Pharma.Aero. Frank Van Gelder, Secretary General at Pharma.Aero, then led a workshop on how, for the industry to be taken seriously in the long term, it needs cross-industry pollination across the entire life science supply chain and logistics community to develop better skills. In the workshop, Van Gelder divided the audience into groups before tasking them with a collaborative project.
The day's sessions concluded with closing remarks from the conference Chair. After a short interval, delegates transferred to FlyPharma's highly anticipated evening networking event in the cellars of the historic Vienna City Hall in central Vienna, the Wiener Rathauskeller. Beginning with welcome drinks and live traditional music, guests were then treated to a gala dinner and a speech from Vienna Airport's Wolfgang Scheibenpflug.
Day 2 on 11 October commenced with breakfast and a recap of day 1 from Chair, Geert Leroy. The opening keynote for the second day was Vatsala Sadasivan, Global Operational Excellence Lead, R&D at Sanofi, who gave a talk on the challenges in applying operational excellence in R&D and developing an operational excellence roadmap. A panel titled 'Logistics Academy for Shippers' then followed, which discussed the difficulties often faced by pharma and biotech shippers in navigating the two highly regulated industries of pharmaceutical manufacturing and logistics.
A morning networking break, sponsored by Lassmann Pharma Logistics and delta T, featured a presentation on the company's specialist pharma services. Gülderen Tuna-Mwale, Regional Sector Head Life Sciences Europe at DHL Global Forwarding, then spoke on the critical topic of 'The Future of the Industry'. Next was a panel on 'Is Sustainability the Key to Better Business?', where the conference heard key questions raised and answered on 'what is each stakeholder's active sustainability goal over the next 5-10 years?', 'how do these goals blend together within the supply chain?' and 'what does "air cargo sustainability" mean for each stakeholder, and how can each contribute?'
This was followed by the closing keynote speaker, Alexandru Popa, Associate Director - Blockchain for Digital Supply Chain at MSD. He gave a talk on 'Enhancing Pharmaceutical Supply Chain Resilience Through Blockchain', which covered topics such as the pharma supply chain's digital evolution, how collaboration makes us all more resilient and the future of the industry.
The conference then heard closing remarks from the Chair, who invited host sponsor Vienna Airport's representatives to the stage, alongside FlyPharma Europe's organizers, for a final photo opportunity. Lunch and further networking preceded an exclusive site tour of Vienna Airport's Pharma Handling Center and cargo facilities, which concluded the event.
The FlyPharma Conferences team would like to thank all speakers and sponsors for their contribution towards making this event a success.
FlyPharma Europe will return for its eighth year in 2024. Full details for the next conference will be announced soon.
Visit the FlyPharma Europe website at www.FlyPharmaEurope.com for more details on this year's event and to register your interest for future conferences.
Press contact information:
Sunday Wilson, Marketing and Content Executive: swilson@pmlive.com
Angela Heath, Conference Director: angela@samedanltd.com
Tel: +44 (0)20 7724 3456
Samedan Ltd, 44 Maiden Lane, London WC2E 7LN, UK
About FlyPharma Conferences, Samedan Ltd and PMGroup Worldwide:
FlyPharma Conferences are aimed at forward-thinking individuals and businesses that are ready to uncover the potential in their pharma supply chains. The event offers an interactive platform to discuss current and future challenges within pharma and cargo, with topics including market trends, cold chain innovations, latest regulatory demands, security technology, and how to encourage collaboration between supply chain players. FlyPharma Conferences are run by specialist pharmaceutical publisher Samedan Ltd, which produces a range of market-leading magazines for senior and middle-management professionals across the global pharma and life sciences sectors. In 2021, Samedan Ltd became part of PMGroup Worldwide Ltd and Datateam Media Group. The acquisition brings together three publishing powerhouses in the pharmaceutical and healthcare sector. As well as joining forces with established titles like PME, PharmaTimes and digital products PMLiVE and pharmatimes.com, PMGroup run a number of awards programmes which recognise best practice in the pharma and healthcare sectors. The union has allowed all brands to expand their readership and their live, virtual and hybrid events and award schemes.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release FlyPharma Conference Europe 2023 shares industry collaboration initiatives and explores the future of pharma logistics here
News-ID: 3257234 • Views: …
More Releases from Samedan Ltd

FlyPharma 2025 Amsterdam officially announced as contracts are signed with host …
FlyPharma, the leading platform for the pharmaceutical logistics and supply chain industry, is thrilled to announce its ninth European conference, which will take place in Amsterdam from October 8-9, 2025. The FlyPharma Amsterdam 2025 conference will convene industry experts to explore the unique challenges and opportunities facing the region and beyond. In a first for FlyPharma, this year's event is supported by three host sponsors: Amsterdam Airport Schiphol, Air France…
FlyPharma 2024: An Event to Remember
FlyPharma Vienna 2024 has officially concluded! The landmark event successfully united industry professionals, expert speakers and delegates, from notable companies such as Sanofi, Takeda, Bayer, Amgen, Octapharma, Lufthansa, IATA, DHL, DoKaSch, Kühne + Nagel and more. Hosted in the historic city of Vienna, this year's conference highlighted actionable solutions and groundbreaking ideas aimed at advancing the future of pharma logistics and supply chains.
The event launched with hands-on workshops, including a…

FlyPharma Vienna 2024: FlyPharma's Exclusive Gala Dinner, An Evening of Elegance …
In just two weeks, the industry leading FlyPharma Conference is set to return. Join industry professionals, expert speakers and delegates from notable companies such as Sanofi, Takeda, Bayer, Amgen, Octapharma, Lufthansa, IATA, DHL, DoKaSch, Kühne + Nagel and more, to tackle key challenges in global pharmaceutical logistics and supply chains.
This unmissable event offers a unique platform for networking, discussion, and collaboration through expert-led sessions, insightful workshops, panel discussions, and…

Agenda Announced for FlyPharma Vienna 2024!
FlyPharma Vienna 2024's agenda is now live on the conference website. As the global pharmaceutical landscape continues to evolve at an unprecedented pace, FlyPharma remains at the forefront, set to address the critical collaboration of pharmaceuticals and air cargo.
The highly anticipated conference, which takes place on 23-24 October 2024 at Office Park 4, Vienna AirportCity promises to deliver unparalleled insights, discussions, and solutions, spotlighting key topics that shape the current…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…